Back to Atlas
APotentially durableStandard research/education caution
CMP-0076
Discontinued/controlled in many markets
Methenolone enanthate / Primobolan Depot
Ergogenic / AAS
Long-acting mild anabolic/lean-tissue preservation effect
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Esterified DHT-derived AAS
- Primary mechanism
- Methenolone prodrug; A:A ratio ~88:44-57
- Primary market use
- Anabolic therapy/performance misuse
Pharmacology
- Molecular weight (Da)
- 414.62
- Oral bioavailability
- N/A (injectable ester)
- Half-life
- ~7-10 d release-dependent
- Route tags
- Route-dependent / verify
- Evidence level
- Historical/clinical
- Clinical status
- Discontinued/controlled in many markets
- Value-for-money score
- 7 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Same base methenolone ratio; enanthate ester extends release.